Target intelligence / Profile preview

Aurora kinase (AURK) (AURK)

Target
AURK
Molecular classification
Enzyme, Serine/threonine-protein kinase
01

Overview

Aurora kinases are a family of highly conserved serine/threonine kinases—specifically Aurora A, Aurora B, and Aurora C—that serve as master regulators of the mitotic phase of the cell cycle (PubMed: 15549033). Aurora A is critical for centrosome maturation and spindle assembly, while Aurora B functions as a catalytic component of the chromosomal passenger complex (CPC) to regulate chromosome-microtubule attachment and cytokinesis (UniProt: O14965, Q96GD4). Aurora C is primarily expressed in germ cells and plays a specialized role in meiosis, though it is also found overexpressed in certain cancers (PubMed: 15146186). Due to their frequent overexpression in various human malignancies, including breast, colon, and lung cancers, these kinases are significant targets for anti-cancer drug development (StatPearls: NBK560640). Therapeutic strategies involve small-molecule inhibitors that typically compete with ATP for the kinase binding site, leading to mitotic arrest, polyploidy, and eventually apoptosis in tumor cells (PubMed: 24107125). Clinical challenges include managing off-target effects and dose-limiting toxicities such as myelosuppression (PubMed: 21460330).

Other names
Aurora-AAurora-BAurora-CSerine/threonine-protein kinase 6Serine/threonine-protein kinase 12Serine/threonine-protein kinase 13STK15STK12STK13AIKBTAKARK1ARK2
02

Mechanism of action

ATP-competitive inhibition of Aurora kinase activity, which disrupts mitotic spindle assembly and chromosome segregation, leading to mitotic catastrophe and apoptosis (PubMed: 24107125).

03

Biological functions

Cell cycle regulationMitosisCentrosome maturationSpindle assemblyChromosome segregationCytokinesisMeiosis
04

Disease associations

CancerBreast cancerColorectal cancerLeukemiaLung cancerOvarian cancer
05

Safety considerations

Neutropenia (PubMed: 21460330)MyelosuppressionGastrointestinal toxicityAlopeciaFatigue
06

Interacting drugs

Alisertib (MLN8237)

6 more in the full profile.

07

Biomarkers

AURKA overexpression (PubMed: 15549033)AURKB overexpressionPhospho-histone H3 (Ser10) levelsCentrosome amplification

Beyond the preview

Go deeper on Aurora kinase (AURK) (AURK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora kinase (AURK) (AURK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call